Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BI 3706674 |
| Trade Name | |
| Synonyms | BI-3706674|BI3706674 |
| Drug Descriptions |
BI 3706674 is a selective KRAS inhibitor, which non-covalently binds KRAS wild-type and mutant alleles, including G12A/C/D/V, G13D, and Q61H, potentially inhibiting Kras signaling and tumor growth (Cancer Res (2024) 84 (6_Supplement): 3317). |
| DrugClasses | KRAS Inhibitor 30 |
| CAS Registry Number | NA |
| NCIT ID | C202247 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BI 1701963 + BI 3706674 | BI 1701963 BI 3706674 | 0 | 0 |
| BI 3706674 | BI 3706674 | 0 | 1 |
| BI 3706674 + Cetuximab | BI 3706674 Cetuximab | 0 | 0 |